Tofacitinib en el tratamiento de la colitis ulcerosa: Casos clínicos

Keyphrases

• Ulcerative Colitis 100%
• Tofacitinib 100%
• Biological Therapy 66%
• Conventional Treatment 33%
• Clinical Situation 33%
• Remission 33%
• Anti-tumor Necrosis Factor (anti-TNF) 33%
• Drug Class 33%
• Anti-TNF Therapy 33%
• Secondary Loss of Response 33%
• Severe Ulcerative Colitis 33%
• JAK-STAT Pathway 33%
• Oral Small Molecules 33%
• Treatment Therapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Ulcerative Colitis 100%
• Tofacitinib 100%
• Tumor Necrosis Factor 50%
• Remission 25%

Biochemistry, Genetics and Molecular Biology

• Tofacitinib 100%
• Tumor Necrosis Factor 66%
• Small Molecule 33%